These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 10526058)

  • 21. Proliferative potential and K-ras mutation in epithelial hyperplasia of the gallbladder in patients with anomalous pancreaticobiliary ductal union.
    Tanno S; Obara T; Fujii T; Mizukami Y; Shudo R; Nishino N; Ura H; Klein-Szanto AJ; Kohgo Y
    Cancer; 1998 Jul; 83(2):267-75. PubMed ID: 9669809
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Losses of heterozygosity on chromosomes 17p and 9p/18q may play important roles in early and advanced phases of gallbladder carcinogenesis.
    Hidaka E; Yanagisawa A; Sakai Y; Seki M; Kitagawa T; Setoguchi T; Kato Y
    J Cancer Res Clin Oncol; 1999; 125(8-9):439-43. PubMed ID: 10480335
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TP53 mutations in stage I gallbladder carcinoma with special attention to growth patterns.
    Hanada K; Itoh M; Fujii K; Tsuchida A; Hirata M; Iwao T; Eguchi N; Sasaki T; Matsubara K; Kajiyama G
    Eur J Cancer; 1997 Jun; 33(7):1136-40. PubMed ID: 9376195
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High frequency of TP53 but not K-ras gene mutations in Bolivian patients with gallbladder cancer.
    Asai T; Loza E; Roig GV; Ajioka Y; Tsuchiya Y; Yamamoto M; Nakamura K
    Asian Pac J Cancer Prev; 2014; 15(13):5449-54. PubMed ID: 25041017
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic alterations involved in the development of gallbladder carcinomas from Greek patients.
    Saetta A; Lazaris AC; Michalopoulos NV; Davaris PS
    Hepatogastroenterology; 2001; 48(41):1284-8. PubMed ID: 11677947
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Frequency of K-ras mutation in biliary and pancreatic tumors].
    Roa JC; Anabalón L; Tapia O; Melo A; de Aretxabala X; Roa I
    Rev Med Chil; 2005 Dec; 133(12):1434-40. PubMed ID: 16446870
    [TBL] [Abstract][Full Text] [Related]  

  • 27. p53 protein overexpression in gallbladder carcinoma and its precursor lesions: an immunohistochemical study.
    Wistuba II; Gazdar AF; Roa I; Albores-Saavedra J
    Hum Pathol; 1996 Apr; 27(4):360-5. PubMed ID: 8617479
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The value of p53 protein expression in gallbladder carcinoma: analysis of 60 cases.
    da Rocha AO; Coutinho LM; Scholl JG; Leboutte LD
    Hepatogastroenterology; 2004; 51(59):1310-4. PubMed ID: 15362740
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic alterations in sporadic and Crohn's-associated adenocarcinomas of the small intestine.
    Rashid A; Hamilton SR
    Gastroenterology; 1997 Jul; 113(1):127-35. PubMed ID: 9207270
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TP53 abnormalities are frequent and early events in the sequential pathogenesis of gallbladder carcinoma.
    Moreno M; Pimentel F; Gazdar AF; Wistuba II; Miquel JF
    Ann Hepatol; 2005; 4(3):192-9. PubMed ID: 16177659
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [P53 gene mutation in gallbladder cancer].
    Roa I; Melo A; Roa J; Araya J; Villaseca M; de Aretxabala X
    Rev Med Chil; 2000 Mar; 128(3):251-8. PubMed ID: 10962865
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of BAT-26 as an indicator of microsatellite instability in gallbladder carcinomas.
    Saetta A; Koilakou SV; Michalopoulos NV; Davaris PS
    Hepatogastroenterology; 2003; 50(54):1799-802. PubMed ID: 14696408
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ras p21 protein immunoreactivity and its relationship to p53 expression and prognosis in gallbladder and extrahepatic biliary carcinoma.
    Lee CS
    Eur J Surg Oncol; 1997 Jun; 23(3):233-7. PubMed ID: 9236898
    [TBL] [Abstract][Full Text] [Related]  

  • 34. K-ras oncogene mutation in cancer and precancerous lesions of the gallbladder.
    Kim SW; Her KH; Jang JY; Kim WH; Kim YT; Park YH
    J Surg Oncol; 2000 Dec; 75(4):246-51. PubMed ID: 11135265
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlation of p53 protein expression with gene mutation in gall-bladder carcinomas.
    Itoi T; Watanabe H; Yoshida M; Ajioka Y; Nishikura K; Saito T
    Pathol Int; 1997 Aug; 47(8):525-30. PubMed ID: 9293532
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gallbladder cancer: a morphological and molecular update.
    Goldin RD; Roa JC
    Histopathology; 2009 Aug; 55(2):218-29. PubMed ID: 19490172
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High frequency of p53 gene mutation in adenocarcinomas of the gallbladder.
    Fujii K; Yokozaki H; Yasui W; Kuniyasu H; Hirata M; Kajiyama G; Tahara E
    Cancer Epidemiol Biomarkers Prev; 1996 Jun; 5(6):461-6. PubMed ID: 8781743
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic Changes of P
    Shukla SK; Singh G; Shahi KS; Bhuvan ; Pant P
    J Gastrointest Cancer; 2020 Jun; 51(2):552-559. PubMed ID: 31396884
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Expression of p53 in gallbladder carcinoma and in dysplastic and metaplastic lesions of the surrounding mucosa].
    Billo P; Marchegiani C; Capella C; Sessa F
    Pathologica; 2000 Aug; 92(4):249-56. PubMed ID: 11029885
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intracholecystic papillary-tubular neoplasms (ICPN) of the gallbladder (neoplastic polyps, adenomas, and papillary neoplasms that are ≥1.0 cm): clinicopathologic and immunohistochemical analysis of 123 cases.
    Adsay V; Jang KT; Roa JC; Dursun N; Ohike N; Bagci P; Basturk O; Bandyopadhyay S; Cheng JD; Sarmiento JM; Escalona OT; Goodman M; Kong SY; Terry P
    Am J Surg Pathol; 2012 Sep; 36(9):1279-301. PubMed ID: 22895264
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.